MTOR and schizophrenia: The mechanistic target of rapamycin (mTOR), also known as mammalian target of rapamycin, represents a critical integrator of neuronal activity and synaptic inputs that plays a role in schizophrenia and other neuropsychiatric diseases (Costa-Mattioli and Monteggia, 2013; Gururajan and Van Den Buuse, 2014; Pham et al., 2016; Chadha and Meador-Woodruff, 2020).